Interleukin-6 and statin therapy: potential role in the management of COPD

@inproceedings{Young2013Interleukin6AS,
  title={Interleukin-6 and statin therapy: potential role in the management of COPD},
  author={Robert Peter Young and Raewyn J. Hopkins},
  booktitle={Respiratory Research},
  year={2013}
}
We read with interest the article by Ferrari and colleagues, showing in a small prospective study of chronic obstructive pulmonary disease (COPD) patients, that interleukin-6 (IL-6) is a useful biomarker predicting worsening exercise tolerance and greater mortality [1]. We outline below the significance of this finding and its potential impact on the future management of COPD. 
3
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 15 REFERENCES

Pharmacological actions of statins: potential utility in COPD.

  • European respiratory review : an official journal of the European Respiratory Society
  • 2009
VIEW 6 EXCERPTS

High-sensitivity C-reactive protein levels and cancer mortality.

  • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 2012
VIEW 1 EXCERPT

N-C: Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin

Lee T-M, Lin M-S, Chang
  • Am J Cardiol
  • 2008
VIEW 2 EXCERPTS